Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
12/18/2003 | WO2003104412A2 Spliceosome mediated rna trans-splicing and correction of factor viii genetic defects using spliceosome mediated rna trans spling |
12/18/2003 | WO2003104411A2 Bioartificial liver system |
12/18/2003 | WO2003104409A2 Maintenance of islet cells |
12/18/2003 | WO2003104402A2 Non-polymeric hematopoietic cell clots for delivery of active agents |
12/18/2003 | WO2003104393A2 Three dimensional vaginal tissue model containing immune cells |
12/18/2003 | WO2003104385A1 Device for multiple simultaneous gene transfer |
12/18/2003 | WO2003104313A1 Porous gelatin material, gelatin structures, methods for preparation of the same and uses thereof |
12/18/2003 | WO2003104272A1 Immunogenic compositions |
12/18/2003 | WO2003104259A2 PEPTIDES PRESENTED BY HLA-B18 AND Cw16 MOLECULES, AND USES THEREOF |
12/18/2003 | WO2003103813A2 Materials and reactor systems having humidity and gas control |
12/18/2003 | WO2003103725A1 Compositions and methods for the diagnosis and treatment of tumor |
12/18/2003 | WO2003103720A2 Compositions and methods for the use of bcl-2 transfected neurons |
12/18/2003 | WO2003103707A1 New method and composition for producing a cellular allogeneic vaccine |
12/18/2003 | WO2003103613A2 Induction of insulin expression |
12/18/2003 | WO2003103611A2 Methods and compositions for the repair and/or regeneration of damaged myocardium |
12/18/2003 | WO2003103607A2 Viral envelope mediated fusion assay |
12/18/2003 | WO2003103597A2 Methods of diagnosing & treating diabetes and insulin resistance |
12/18/2003 | WO2003103581A2 Compositions and methods for liver growth and liver protection |
12/18/2003 | WO2003103577A2 Novel recombinant anticoagulant proteins |
12/18/2003 | WO2003103573A2 Methods for treating a neurological disorder by peripheral administration of a trophic factor |
12/18/2003 | WO2003103390A1 Sterilization, stabilization and preservation of functional biologics |
12/18/2003 | WO2003103389A2 Cryopreservation of haptenized tumor cells |
12/18/2003 | WO2003080660A3 Method for the preparation of recombinant mammalian heparin-binding protein (hbp) |
12/18/2003 | WO2003078967A3 Stem cell selection and differentiation |
12/18/2003 | WO2003074692A3 Specific gene expression in colonic cancer cell lines |
12/18/2003 | WO2003074558A3 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom |
12/18/2003 | WO2003066847A3 Phytase variants |
12/18/2003 | WO2003059953A3 Anti-idiotypic antibody inducing hiv-1 neutralizing antibodies |
12/18/2003 | WO2003058248A3 Diagnostics and vaccines for mycrobacterium paratuberculosis infections |
12/18/2003 | WO2003057911A3 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy |
12/18/2003 | WO2003057159A3 Psoriasin expression by breast epithelial cells |
12/18/2003 | WO2003054160A3 Cell lines with latent immunodeficiency virus and methods of use thereof |
12/18/2003 | WO2003052054A3 Bgl5 beta-glucosidase and nucleic acids encoding the same |
12/18/2003 | WO2003051917A3 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
12/18/2003 | WO2003051907A3 Method of enhancing immunogenicity by covalent linkage of antigens to proteins on the surface of dendritic cells |
12/18/2003 | WO2003046179A3 G-protein coupled receptor lustr2 and uses thereof |
12/18/2003 | WO2003046131A3 Dnmt3l-related cloning and reproductive methods |
12/18/2003 | WO2003042405A3 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
12/18/2003 | WO2003040336A3 Stem and progenitor cell capture for tissue regeneration |
12/18/2003 | WO2003040309A3 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
12/18/2003 | WO2003031608A3 Mutated abl kinase domains |
12/18/2003 | WO2003029444A3 Method and device for extracting secondary plant constituents |
12/18/2003 | WO2003029437A3 Secreted proteins |
12/18/2003 | WO2003027244A3 Antisense oligonucleotides and methods to induce tumor cell death |
12/18/2003 | WO2003026578A3 Pine cone extracts and uses thereof |
12/18/2003 | WO2003025163A3 Lactobacillus n-deoxyribosyl transferases, corresponding nucleotide sequences and their uses |
12/18/2003 | WO2003025149A3 Cell populations which co-express cd49c and cd90 |
12/18/2003 | WO2003024297A3 Cell storage and delivery system |
12/18/2003 | WO2003020896A9 Production of cultured human mast cells and basophils for high throughput small molecule drug discovery |
12/18/2003 | WO2003018810A3 Modified cry3a toxins and nucleic acid sequences coding therefor |
12/18/2003 | WO2003014342A3 Identification of a dna variant associated with adult type hypolactasia |
12/18/2003 | WO2003004684A9 NUCLEIC ACIDS ENCODING A RECOMBINANT 250 kDa ANTIGEN FROM SPOROZOITES/MEROZOITES OF EIMERIA MAXIMA AND THEIR USES |
12/18/2003 | WO2003000864A8 Nucleic acid-associated proteins |
12/18/2003 | WO2002099095A3 Improved isoprenoid production |
12/18/2003 | WO2002099035A3 Chimeric alphavirus replicon particles |
12/18/2003 | WO2002097045A3 Neuroblastoma cell lines expressing the alpha2delta subunit of calcium channels and methods therefore |
12/18/2003 | WO2002090509A3 Materials and methods for producing tomato yellow leaf curl virus resistance in plants |
12/18/2003 | WO2002085305A3 Compositions and methods for inducing cancer cell death |
12/18/2003 | WO2002081668A3 Desaturase genes and uses thereof |
12/18/2003 | WO2002079456B1 A method for the preparation of immunologically inert amniotic membranes |
12/18/2003 | WO2002079388A3 Modulation of mhc class i antigen presentation |
12/18/2003 | WO2002078599A3 CD8α + LYMPHOID DENDRITIC CELL DIFFERENTIATED FROM HUMAN HEMATOPOIETIC STEM CELL AND A METHOD FOR DIFFERENTIATION |
12/18/2003 | WO2002074157A3 A mammalian immortalized liver cell |
12/18/2003 | WO2002070660A3 Proteins and nucleic acids encoding same |
12/18/2003 | WO2002064740A3 Cone snail peptides |
12/18/2003 | WO2002057423A3 Isolating cells expressing secreted proteins |
12/18/2003 | WO2002051980A9 In vitro-derived adult pluripotent stem cells and uses therefor |
12/18/2003 | WO2000065025A3 Dna molecules encoding human endothelin converting enzyme 3 |
12/18/2003 | US20030233681 ICE1, a regulator of cold induced transcriptome and freezing tolerance in plants |
12/18/2003 | US20030233669 Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses |
12/18/2003 | US20030232975 Comprises nucleotide sequences coding polypeptides for diagnosing, preventing and treating cancer |
12/18/2003 | US20030232752 Proliferated cell lines and uses thereof |
12/18/2003 | US20030232750 Indolicidin peptide analogues containing at least two basic amino acids; bactericide |
12/18/2003 | US20030232433 The use of stem cells and CD6 depleted stem cells for the induction of tolerance to allogenic transplants and/or for the treatment of leucemia |
12/18/2003 | US20030232432 Culturing mesenchymal stem cells for use in treating cancer, diabetes and nervous system disorders; regenerative medicine |
12/18/2003 | US20030232431 Cellular transplantation for heart regeneration |
12/18/2003 | US20030232430 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells |
12/18/2003 | US20030232429 System for culturing human cells and tissues |
12/18/2003 | US20030232414 Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter |
12/18/2003 | US20030232404 Comprises heat resistant beetle luciferase with increased half-life for use as diagnostic tool in genetic engineering |
12/18/2003 | US20030232387 Antibodies that bind alphaE integrin |
12/18/2003 | US20030232377 Based on fetal cells present in peripheral maternal blood; a method for isolating fetal cells from maternal blood |
12/18/2003 | US20030232360 An in vitro system that recapitulates regulated mRNA stability and turnover of exogenous RNA substrates; used to identify agents capable of modulating RNA turnover in the presence of RNA stability modifying agents |
12/18/2003 | US20030232358 Identifying the genetic factors responsible for cell differentiation based on expression cloning |
12/18/2003 | US20030232357 A heat-stable enzyme having a DNA helicase activity, and a structure-specific endonuclease activity; obtained by cloning a gene encoding the enzyme from chromosomal DNA of a a sulfur-metabolizing thermophilic archaebacteria |
12/18/2003 | US20030232350 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer |
12/18/2003 | US20030232349 Nucleic acid and amino acid sequences of proteases and the use of these sequences in the diagnosis and treatment of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, and neurological disorders |
12/18/2003 | US20030232339 Human TRPCC cation channel and uses |
12/18/2003 | US20030232334 Novel compositions and methods for cancer |
12/18/2003 | US20030232058 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
12/18/2003 | US20030232050 Compositions and methods for regulating angiogenesis |
12/18/2003 | US20030232041 For use in food and feeds |
12/18/2003 | US20030232036 Alphavirus RNA replicon systems |
12/18/2003 | US20030232035 Capable of expressing a heterologous sequence in target cells; vaccines |
12/18/2003 | US20030232022 P. gingivalis antigenic composition |
12/18/2003 | CA2855445A1 Methods and compositions for production of maize lines with increased transformability |
12/18/2003 | CA2489076A1 Cryopreservation of haptenized tumor cells |
12/18/2003 | CA2488778A1 Assay to detect replication competent viruses |
12/18/2003 | CA2488774A1 Immunomodulation using altered dendritic cells |
12/18/2003 | CA2488744A1 Compositions and methods for the use of bcl-2 transfected neurons |